Twists and turns in the race to be SA’s first widely used HIV prevention injection

Posted in: Access to Medicines, Focus, Healthcare system, HIV/AIDS, InFocus, Latest, Spotlight

The health department has plans to roll out lenacapavir, a twice-yearly HIV prevention injection, in a select group of public sector clinics by April 2026. Meanwhile, little progress has been made towards rolling out a two-monthly prevention injection, despite the four-year head start this product had on lenacapavir. Catherine Tomlinson reports.

Twists and turns in the race to be SA’s first widely used HIV prevention injection

Women in SA could have access to a three-monthly HIV prevention ring by 2026

Posted in: Access to Medicines, Focus, Healthcare system, HIV/AIDS, InFocus, Latest, Spotlight

A flexible silicone ring that slowly releases antiretrovirals is one of just two long-acting HIV prevention products registered for use in South Africa. Results from a new study might pave the way for a longer-acting version of the vaginal ring that provides three months of protection at a time, as opposed to one month with the current ring. Elri Voigt reports on these findings and looks at how the one-month ring has influenced HIV prevention choices in South Africa.